Decode the differences between Indian Pharmacopoeia, British Pharmacopoeia, and United States Pharmacopeia standards.
The Three Major Pharmacopoeias
Pharmacopoeias are official compilations of quality standards for pharmaceutical substances and drug products. Three dominate global pharmaceutical manufacturing:
- IP: Indian Pharmacopoeia (Indian Pharmacopoeia Commission)
- BP: British Pharmacopoeia (UK Medicines and Healthcare products Regulatory Agency)
- USP: United States Pharmacopeia (United States Pharmacopeial Convention)
Indian Pharmacopoeia (IP)
The IP is the legal standard for all drugs marketed in India under the Drugs and Cosmetics Act, 1940. CDSCO (Central Drugs Standard Control Organization) enforces IP compliance. The current edition is IP 2022.
Key features:
- Contains monographs for APIs, excipients, dosage forms, and biologicals
- General chapters on test methods, reagents, and apparatus
- IP Reference Substances (IPRS) are the official standards
British Pharmacopoeia (BP)
Published annually by the UK MHRA, the BP is a reference standard for substances and preparations used in the UK and is cited in many European regulatory submissions. It's widely used in India for imported APIs and for companies seeking UK/EU market access.
BP Chemical Reference Substances (BPCRS) are certified by the BP laboratory.
United States Pharmacopeia (USP)
The USP is the reference standard for drugs marketed in the United States and is recognized by the FDA. USP Reference Standards (USP-RS) are highly characterized materials with certified purity, used as the benchmark for analytical testing.
The USP is particularly important for companies exporting to the US market or manufacturing for multinational pharma companies.
Key Differences
| Aspect | IP | BP | USP |
|---|---|---|---|
| Authority | IPC/CDSCO | MHRA | FDA/USP Convention |
| Primary market | India | UK/Europe | USA |
| Reference standards | IPRS | BPCRS | USP-RS |
| Test methods | Similar but distinct | Similar to EP | Some unique methods |
Harmonisation
The International Council for Harmonisation (ICH) has driven significant convergence between USP, BP (via EP), and JP. Many general chapters and analytical methods are now harmonised across pharmacopoeias. However, specific monographs may still differ in acceptance criteria.
Sourcing Pharmacopoeial Standards
Upashna Enterprises supplies IP, BP, and USP grade reference standards from authorized producers including Merck, Sigma Aldrich, and Scharlau — with full documentation and traceability certificates.